Significant differences in drug susceptibility among species in the Candida parapsilosis group

Area of Science:

• Medical Mycology
• Antimicrobial Resistance

Background:

• The Candida parapsilosis species complex is a significant opportunistic fungal pathogen.
• Accurate species identification is crucial for effective antifungal therapy.

Purpose of the Study:

• To investigate the antifungal susceptibility differences among the three proposed species within the Candida parapsilosis complex: C. parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis.
• To assess the clinical implications of these species-specific differences in antifungal drug response.

Main Methods:

• Antifungal susceptibility testing was performed to determine Minimum Inhibitory Concentrations (MICs) for caspofungin (CAS), anidulafungin, and fluconazole.
• Statistical analysis was employed to compare MICs and the incidence of paradoxical growth among the species.

Main Results:

• Candida parapsilosis sensu stricto demonstrated significantly higher MICs for caspofungin and anidulafungin compared to C. orthopsilosis and C. metapsilosis.
• Candida metapsilosis exhibited the lowest susceptibility to fluconazole.
• A higher frequency (37%) of paradoxical growth in the presence of caspofungin was observed in C. parapsilosis sensu stricto (P <= 0.02).

Conclusions:

• Distinct antifungal susceptibility profiles exist among the species within the Candida parapsilosis complex.
• These variations, particularly the increased resistance to echinocandins and paradoxical growth in C. parapsilosis sensu stricto, may necessitate tailored therapeutic strategies.